Table 2 |
|||||
|
The most common treatments prescribed for non-malarial febrile illnesses |
|||||
|
Treatments* |
Total (%) n = 1602 |
Age < 5 years (%) n = 742 |
Age ≥ 5 years (%) n = 860 |
RR† (95%CI) |
p-value |
|
|
|||||
|
Paracetamol |
1448 (90%) |
655 (88%) |
793 (92%) |
1.0 (1.0–1.2) |
0.003 |
|
Cough syrups |
767 (48%) |
394 (53%) |
373 (43%) |
1.2 (1.1–1.4) |
0.0001 |
|
Vitamin C |
696 (43%) |
363 (49%) |
333 (39%) |
1.3 (1.1–1.4) |
<0.001 |
|
Amoxicillin |
457 (29%) |
233 (31%) |
224 (26%) |
1.2 (1.0–1.4)) |
0.018 |
|
Other antibiotics |
332 (21%) |
181 (24%) |
151 (18%) |
1.4 (1.1–1.7) |
0.001 |
|
Oral rehydration salts |
199 (12%) |
111 (15%) |
88 (10%) |
1.5 (1.1–1.9) |
0.004 |
|
Vitamin A |
63 (4%) |
35 (5%) |
28 (3%) |
1.5 (0.9–2.4) |
0.134 |
|
|
|||||
|
* Patients may have been given more than one treatment † RR = Relative risk for age < 5 years versus age ≥ 5 years |
|||||
|
Njama-Meya et al. Malaria Journal 2007 6:7 doi:10.1186/1475-2875-6-7 |
|||||